1. Flavonoids in the Treatment of Diabetes: Clinical Outcomes and Mechanism to Ameliorate Blood Glucose Levels
    Dunya Al Duhaidahawi et al, 2021, Current Diabetes Reviews CrossRef
  2. Liraglutide Attenuates Hepatic Oxidative Stress, Inflammation, and Apoptosis in Streptozotocin-Induced Diabetic Mice by Modulating the Wnt/β-Catenin Signaling Pathway
    Jie Yu et al, 2023, Mediators of Inflammation CrossRef
  3. Liraglutide Increases Serum Levels of MicroRNA-27b, -130a and -210 in Patients with Type 2 Diabetes Mellitus: A Novel Epigenetic Effect
    Rosaria Vincenza Giglio et al, 2020, Metabolites CrossRef
  4. NADPH Oxidase 2-Mediated Insult in the Auditory Cortex of Zucker Diabetic Fatty Rats
    Zheng-De Du et al, 2019, Neural Plasticity CrossRef
  5. Liraglutide Regulates the Kidney and Liver in Diabetic Nephropathy Rats through the miR-34a/SIRT1 Pathway
    Shan Xiao et al, 2021, Journal of Diabetes Research CrossRef
  6. Metabolic responses and benefits of glucagon‐like peptide‐1 (GLP‐1) receptor ligands
    Neil Tanday et al, 2022, British Journal of Pharmacology CrossRef
  7. Context-Dependent Regulation of Nrf2/ARE Axis on Vascular Cell Function during Hyperglycemic Condition
    Tharmarajan Ramprasath et al, 2020, Current Diabetes Reviews CrossRef
  8. Naringin attenuates fructose-induced NAFLD progression in rats through reducing endogenous triglyceride synthesis and activating the Nrf2/HO-1 pathway
    Sirinat Pengnet et al, 2022, Frontiers in Pharmacology CrossRef